Is Current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort

Inflammatory Bowel Diseases

Volumn 19, Issue 4, 2013, Pages 1010-1017

  Lakatos, Peter L ^a   Vegh, Zsuzsanna ^a   Lovasz, Barbara D ^a   David, Gyula ^b   Pandur, Tunde ^b   Erdelyi, Zsuzsanna ^b   Szita, Istvan ^b   Mester, Gabor ^c   Balogh, Mihaly ^c   Szipocs, Istvan ^d   Molnar, Csaba ^e   Komaromi, Erzsebet ^a,d   Mandel, Michael ^a   Horvath, Agnes ^b   Szathmari, Miklos ^a   Kiss, Lajos S ^a   Lakatos, Laszlo ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Csolnoky F Province Hospital   (Hungary)

^c Grof Eszterhazy Hospital   (Hungary)

^d Municipal Hospital   (Hungary)

^e Magyar Imre Hospital   (Hungary)

Author keywords

Crohn's disease; Disease course; Disease risk; Smoking; Ulcerative colitis

Indexed keywords

STEROID; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGE; ARTHRITIS; COLON; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENTERITIS; FEMALE; HUMAN; ILEUM; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SMOKING; ULCERATIVE COLITIS; ADOLESCENT; AGED; ARTICLE; BEHAVIOR; COLON RESECTION; DATA BASE; ENVIRONMENTAL FACTOR; GENDER; HOSPITAL PATIENT; OUTPATIENT; POPULATION; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUNGARY; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 84874646937     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e3182802b3e     Document Type: Review

References (40)

1. Lakatos PL, Fischer S, Lakatos L, et al. Current concept on the pathogenesis of IBD: crosstalk between genetic and microbial factors. Pathogenic bacteria, altered bacterial sensing or changes in mucosal integrity take "toll"? World J Gastroenterol. 2006;12:1829-1840.
2. Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol. 2006;12:6102-6108.
3. Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J. 1982;284:706.
4. Somerville KW, Logan RF, Edmond M, et al. Smoking and Crohn's disease. Br Med J. 1984;289:954-956.
5. Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462-1471.
6. Bernstein CN, Rawsthorne P, Cheang M, et al. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol. 2006; 101:993-1002.
7. Mahid SS, Minor KS, Stromberg AJ, et al. Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:431-438.
8. Cosnes J, Nion-Larmurier I, Afchain P, et al. Gender differences in the response of colitis to smoking. Clin Gastroenterol Hepatol. 2004;2:41-48.
9. Srivasta ED, Newcombe RG, Rhodes J, et al. Smoking and ulcerative colitis: a community study. Int J Colorectal Dis. 1993;8:71-74.
10. Mahid SS, Minor KS, Stevens PL, et al. The role of smoking in Crohn's disease as defined by clinical variables. Dig Dis Sci. 2007;52:2897-2903.
11. Lakatos PL, Czegledi Z, Szamosi T., Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease. World J Gastroenterol. 2009;15:3504-3510.
12. Louis E, Michel V, Hugot JP, et al. Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut. 2003;52:552-557.
13. Seksik P, Nion-Larmurier I, Sokol H, et al. Effects of light smoking consumption on the clinical course of Crohn's disease. Inflamm Bowel Dis. 2009;15:734-741.
14. Cosnes J, Carbonnel F, Carrat F, et al. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther. 1999;13:1403-1411.
15. Russel MG, Volovics A, Schoon EJ, et al. Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis. 1998;4:182-186.
16. Szamosi T, Banai J, Lakatos L, et al. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and non-smokers with Crohn's disease, while smoking prevents colectomy in UC. Eur J Gastroenterol Hepatol. 2010;22:872-879.
17. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology. 1996;110:424-431.
18. Boyko EJ, Koepsell TD, Perera DR, et al. Risk of ulcerative colitis among former and current cigarette smokers. N Eng J Med. 1987;316: 707-710.
19. Mokbel M, Carbonnel F, Beaugerie L, et al. Effect of smoking on the long-term course of ulcerative colitis. Gastroenterol Clin Biol. 1998;22: 858-862.
20. Hoie O, Wolters F, Riis L, et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide populationbased cohort. Am J Gastroenterol. 2007;102:1692-1701.
21. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol. 2004;18:481-496.
22. Hoie O, Wolters FL, Riis L, et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology. 2007;132:507-515.
23. Aldhous MC, Drummond HE, Anderson N, et al. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol. 2007;102:589-597.
24. Lakatos L, Kiss LS, David G, et al. Incidence, disease phenotype at diagnosis and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis. 2011;17:2558-2565.
25. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24(suppl 170):2-6.
26. van Assche G, Dignass A, Panes J, et al. The second European evidencebased consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohn Colitis. 2010;4:7-27.
27. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(suppl A):5-36.
28. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology. 1994;106:643-648.
29. Lakatos PL, Golovics PA, David G, et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Am J Gastroenterol. 2012;107:579-588.
30. Aldhous MC, Drummond HE, Anderson N, et al. Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification. Am J Gastroenterol. 2007;102:577-588.
31. Tombor I, Paksi B, Urbán R, et al. Epidemiology of smoking in Hungary- a representative national study. Orv Hetil. 2010;151:330-337.
32. Demjen T, Kiss J, Boti E, et al. Global youth tobacco survey, Nemzetközi ifjúsági dohányzásfelmé rés. 2008. Available at: http://color.oefi.hu/melleklet/GYTS-kutatasi- jelentes.pdf Accessed April 21, 2012.
33. Persson PG, Ahlbom A, Hellers G. Inflammatory bowel disease and tobacco smoke-a case-control study. Gut. 1990;31:1377-1381.
34. Bergeron V, Grondin V, Rajca S, et al. Current smoking differentially affects blood mononuclear cells from patients with Crohn's disease and ulcerative colitis: relevance to its adverse role in the disease. Inflamm Bowel Dis. 2012;18:1101-1111.
35. Lakatos PL. Environmental factors affecting IBD-have we made progress? Dig Dis. 2009;27:215-225.
36. Imielinski M, Baldassano RN, Griffiths A, et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet. 2009;41:1335-1340.
37. Weersma RK, Stokkers PC, van Bodegraven AA, et al. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort. Gut. 2009;58:388-395.
38. Romberg-Camps MJ, Dagnelie PC, Kester AD, et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol. 2009;104:371-383.
39. Reese GE, Nanidis T, Borysiewicz C, et al. The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. Int J Colorectal Dis. 2008;23:1213-1221.
40. Jones DT, Osterman MT, Bewtra M, et al. Passive smoking and inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103: 2382-2393.